70 jobs to be created through new Blarney production facility

70 jobs to be created through new Blarney production facility
Artist rendering of the ILC Dover location in Blarney.

UP to 70 jobs are to be created by a US company setting up a new production facility in Blarney.

ILC Dover, who operate safety equipment and systems for the pharmaceutical and biopharmaceutical industry announced it is expanding its Irish production footprint by opening the new Cork centre.

The project is supported by the Irish Government through IDA Ireland.

The building will be operational in the first quarter of 2019 and outfitted with more than 10,000 square feet of clean rooms capacity dedicated to the company’s pharmaceutical and biopharmaceutical product lines. 

When at full production, the company expects to hire 60 to 70 new ILC Dover employees. The new roles will include management, production, quality, design and support.

The company’s current operation in Little Island will be relocated to the Blarney site as part of the expansion project. In addition to production space, the new facility will contain state-of-the-art offices, meeting rooms and a product demonstration area for client visits.

Welcoming the announcement, Minister for Business, Enterprise & Innovation, Heather Humphreys T.D. said: “Ireland is now a major player and a very attractive location for companies like ILC Dover to grow their operations and I look forward to a mutually beneficial partnership developing."

Mary Buckley, Executive Director, IDA Ireland said: "Manufacturing excellence in pharmaceutical and biopharmaceuticals is a hallmark of Ireland's success in the sector and is one of the primary reasons as to why Ireland is home to 10 of the top 10 global pharmaceutical companies. 

ILC Dover President and CEO Fran DiNuzzo expressed enthusiasm about the new launch: “The expansion of our production capabilities in Ireland will allow us to better serve our global customer base and strengthen our position as the leading single-use powder handling solutions provider to the global pharmaceutical and biopharmaceutical marketplace.” 

Curtis Gingles, Vice President and General Manager of the company’s Pharmaceutical Division, added, “Clients of ILC Dover will be happy to see that we’re focused on providing additional capacity located in the region with expanded technical resources. The market for our products is experiencing incredible growth and this expansion will ensure we can keep up with the growing demand for the high-quality products used in manufacturing lifesaving therapies.”

More in this section

Sponsored Content

Echo 130Echo 130

Podcast: 1000 Cork songs 
Singer/songwriter Jimmy Crowley talks to John Dolan

Listen Here

Add Echolive.ie to your home screen - easy access to Cork news, views, sport and more